{"id":350207,"date":"2026-11-17T14:19:47","date_gmt":"2026-11-17T08:49:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=350207"},"modified":"2026-11-17T14:19:47","modified_gmt":"2026-11-17T08:49:47","slug":"fortis-healthcare-vs-max-healthcare-valuation","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/","title":{"rendered":"Fortis Healthcare vs Max Healthcare Institute 2027: The Market Pays 71x for One Hospital Chain and 57x for the Other"},"content":{"rendered":"<div style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;margin:0 0 16px;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:14px;\">\n<tr>\n<th style=\"text-align:left;padding:4px 10px;\">Fortis Healthcare vs Max Healthcare Institute at a glance<\/th>\n<th style=\"text-align:left;padding:4px 10px;\">Fortis Healthcare<\/th>\n<th style=\"text-align:left;padding:4px 10px;\">Max Healthcare Institute<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>Share price (16 Nov 2026)<\/strong><\/td>\n<td style=\"padding:4px 10px;\">Rs 803.20<\/td>\n<td style=\"padding:4px 10px;\">Rs 1,009.90<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>Market cap<\/strong><\/td>\n<td style=\"padding:4px 10px;\">Rs 60,502 crore<\/td>\n<td style=\"padding:4px 10px;\">Rs 98,306 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>P\/E ratio<\/strong><\/td>\n<td style=\"padding:4px 10px;\">56.96<\/td>\n<td style=\"padding:4px 10px;\">71.23<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>Q2 FY27 net profit<\/strong><\/td>\n<td style=\"padding:4px 10px;\">Rs 320.5 crore<\/td>\n<td style=\"padding:4px 10px;\">Rs 414.4 crore<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Fortis Healthcare vs Max Healthcare Institute compares two of India&#8217;s largest listed hospital chains, both centred on north India. In Q2 FY27, Fortis grew revenue 16.5% to Rs 2,742 crore while net profit slipped 2.5% to Rs 321 crore. Max Healthcare grew revenue 20.4% to Rs 2,610 crore, but net profit fell 15.7% to Rs 414 crore against a high base. Max trades at a P\/E of 71.23 and Fortis at 56.96.<\/p>\n<\/div>\n<p><strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> in 2027 is a question of how much investors will pay for hospital growth: Max Healthcare trades at <strong>71.23 times earnings<\/strong> and Fortis at <strong>56.96 times<\/strong>, even though both reported lower profit in the September 2026 quarter. The <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> valuation premium is built on margins and expansion plans.<\/p>\n<p>Both companies run multi-speciality hospital networks with a strong base in Delhi NCR and other north Indian cities. Max Healthcare Institute is valued at about Rs 98,306 crore and Fortis Healthcare at about Rs 60,502 crore, and both belong to the broader <a href=\"https:\/\/univest.in\/indices\/nifty-500\/nifty-500-share-price-today\">Nifty 500<\/a>. This <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> guide covers business models, valuation, <strong>Q2 FY27 results<\/strong>, 2027 drivers, risks and shareholding.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=fortis-healthcare-vs-max-healthcare-valuation\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_Healthcare_vs_Max_Healthcare_Institute_Company_Overview\" title=\"Fortis Healthcare vs Max Healthcare Institute: Company Overview\">Fortis Healthcare vs Max Healthcare Institute: Company Overview<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#What_Fortis_Healthcare_Does\" title=\"What Fortis Healthcare Does\">What Fortis Healthcare Does<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#What_Max_Healthcare_Institute_Does\" title=\"What Max Healthcare Institute Does\">What Max Healthcare Institute Does<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#How_Fortis_Healthcare_and_Max_Healthcare_Make_Money\" title=\"How Fortis Healthcare and Max Healthcare Make Money\">How Fortis Healthcare and Max Healthcare Make Money<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_Healthcare_vs_Max_Healthcare_Institute_Valuation\" title=\"Fortis Healthcare vs Max Healthcare Institute Valuation\">Fortis Healthcare vs Max Healthcare Institute Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_Healthcare_vs_Max_Healthcare_Institute_Q2_FY27_Results\" title=\"Fortis Healthcare vs Max Healthcare Institute Q2 FY27 Results\">Fortis Healthcare vs Max Healthcare Institute Q2 FY27 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_Healthcare_vs_Max_Healthcare_Valuation_Drivers_for_2027\" title=\"Fortis Healthcare vs Max Healthcare Valuation Drivers for 2027\">Fortis Healthcare vs Max Healthcare Valuation Drivers for 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Max_Healthcare_new_beds_in_premium_markets\" title=\"Max Healthcare: new beds in premium markets\">Max Healthcare: new beds in premium markets<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_network_growth_and_diagnostics\" title=\"Fortis: network growth and diagnostics\">Fortis: network growth and diagnostics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Industry_tailwinds\" title=\"Industry tailwinds\">Industry tailwinds<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Risks_in_Fortis_Healthcare_vs_Max_Healthcare_Institute\" title=\"Risks in Fortis Healthcare vs Max Healthcare Institute\">Risks in Fortis Healthcare vs Max Healthcare Institute<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Risks_for_Fortis_Healthcare\" title=\"Risks for Fortis Healthcare\">Risks for Fortis Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Risks_for_Max_Healthcare_Institute\" title=\"Risks for Max Healthcare Institute\">Risks for Max Healthcare Institute<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_Healthcare_vs_Max_Healthcare_Institute_Shareholding\" title=\"Fortis Healthcare vs Max Healthcare Institute Shareholding\">Fortis Healthcare vs Max Healthcare Institute Shareholding<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Which_Investor_Does_Each_Hospital_Stock_Suit\" title=\"Which Investor Does Each Hospital Stock Suit?\">Which Investor Does Each Hospital Stock Suit?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Fortis_Healthcare_suits_investors_who_want_scale_at_a_lower_multiple\" title=\"Fortis Healthcare suits investors who want scale at a lower multiple\">Fortis Healthcare suits investors who want scale at a lower multiple<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Max_Healthcare_Institute_suits_premium-growth_investors\" title=\"Max Healthcare Institute suits premium-growth investors\">Max Healthcare Institute suits premium-growth investors<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Final_View_on_Fortis_Healthcare_vs_Max_Healthcare_Institute\" title=\"Final View on Fortis Healthcare vs Max Healthcare Institute\">Final View on Fortis Healthcare vs Max Healthcare Institute<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#FAQs_on_Fortis_Healthcare_vs_Max_Healthcare_Institute\" title=\"FAQs on Fortis Healthcare vs Max Healthcare Institute\">FAQs on Fortis Healthcare vs Max Healthcare Institute<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Why_did_Max_Healthcares_profit_fall_in_Q2_FY27\" title=\"Why did Max Healthcare&#x27;s profit fall in Q2 FY27?\">Why did Max Healthcare&#x27;s profit fall in Q2 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#How_did_Fortis_Healthcare_perform_in_Q2_FY27\" title=\"How did Fortis Healthcare perform in Q2 FY27?\">How did Fortis Healthcare perform in Q2 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Why_does_Max_Healthcare_trade_at_a_higher_PE\" title=\"Why does Max Healthcare trade at a higher P\/E?\">Why does Max Healthcare trade at a higher P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Who_is_the_promoter_of_Fortis_Healthcare\" title=\"Who is the promoter of Fortis Healthcare?\">Who is the promoter of Fortis Healthcare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Which_hospital_chain_has_higher_FY26_revenue\" title=\"Which hospital chain has higher FY26 revenue?\">Which hospital chain has higher FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#How_far_are_both_stocks_from_their_52-week_highs\" title=\"How far are both stocks from their 52-week highs?\">How far are both stocks from their 52-week highs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-vs-max-healthcare-valuation\/#Is_Fortis_Healthcare_vs_Max_Healthcare_Institute_a_buy_or_sell_decision\" title=\"Is Fortis Healthcare vs Max Healthcare Institute a buy or sell decision?\">Is Fortis Healthcare vs Max Healthcare Institute a buy or sell decision?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_vs_Max_Healthcare_Institute_Company_Overview\"><\/span><strong>Fortis Healthcare vs Max Healthcare Institute: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_Fortis_Healthcare_Does\"><\/span><strong>What Fortis Healthcare Does<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fortis Healthcare runs a network of multi-speciality and super-speciality hospitals across India, with a strong presence in Delhi NCR, Punjab, Maharashtra, Karnataka and West Bengal. It also owns a majority of Agilus Diagnostics, one of India&#8217;s large pathology chains.<\/p>\n<p>Its promoter is Malaysia&#8217;s IHH Healthcare, which holds 31.17% of the company.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_Max_Healthcare_Institute_Does\"><\/span><strong>What Max Healthcare Institute Does<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Max Healthcare Institute operates a chain of hospitals focused on high-end tertiary and quaternary care, mostly in Delhi NCR and north India. It also runs home care and pathology services linked to its hospitals.<\/p>\n<p>Promoters hold 23.71%. The company is known for high revenue per occupied bed and one of the highest <strong>operating margins<\/strong> among listed hospital chains.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Fortis_Healthcare_and_Max_Healthcare_Make_Money\"><\/span><strong>How Fortis Healthcare and Max Healthcare Make Money<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Both companies earn revenue from inpatient treatment, surgeries, outpatient visits, diagnostics and pharmacy sales. The key measures are bed occupancy, average revenue per occupied bed and the mix of complex treatments such as cardiac, oncology and transplants.<\/p>\n<p>Max focuses on high-value specialties and premium city locations, which supports its higher margin. Its <strong>operating margin<\/strong> was 29.3% in <strong>Q2 FY27<\/strong> against 23.4% for Fortis.<\/p>\n<p>Fortis has a wider network and a diagnostics business that adds scale but runs at lower margins than hospitals. In <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong>, the margin difference is a large part of the valuation gap.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_vs_Max_Healthcare_Institute_Valuation\"><\/span><strong>Fortis Healthcare vs Max Healthcare Institute Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> data uses the 16 November 2026 close and trailing twelve month ratios.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>Fortis Healthcare vs Max Healthcare Institute metric<\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-ltd-share-price-today\">Fortis Healthcare<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\">Max Healthcare Institute<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Share price (CMP)<\/td>\n<td>Rs 803.20<\/td>\n<td>Rs 1,009.90<\/td>\n<\/tr>\n<tr>\n<td>52-week high<\/td>\n<td>Rs 1,010.10<\/td>\n<td>Rs 1,185.40<\/td>\n<\/tr>\n<tr>\n<td>52-week low<\/td>\n<td>Rs 704.95<\/td>\n<td>Rs 797.00<\/td>\n<\/tr>\n<tr>\n<td>Distance from 52-week high<\/td>\n<td>-20.5%<\/td>\n<td>-14.8%<\/td>\n<\/tr>\n<tr>\n<td>Market capitalisation<\/td>\n<td>Rs 60,502 crore<\/td>\n<td>Rs 98,306 crore<\/td>\n<\/tr>\n<tr>\n<td>P\/E ratio (TTM)<\/td>\n<td>56.96<\/td>\n<td>71.23<\/td>\n<\/tr>\n<tr>\n<td>Industry P\/E<\/td>\n<td>62.49<\/td>\n<td>62.49<\/td>\n<\/tr>\n<tr>\n<td>P\/B ratio<\/td>\n<td>5.77<\/td>\n<td>8.68<\/td>\n<\/tr>\n<tr>\n<td>Return on equity (ROE)<\/td>\n<td>9.91%<\/td>\n<td>12.18%<\/td>\n<\/tr>\n<tr>\n<td>Debt to equity<\/td>\n<td>0.30<\/td>\n<td>0.33<\/td>\n<\/tr>\n<tr>\n<td>Dividend yield<\/td>\n<td>0.12%<\/td>\n<td>0.20%<\/td>\n<\/tr>\n<tr>\n<td>FY26 revenue<\/td>\n<td>Rs 9,178 crore<\/td>\n<td>Rs 8,536 crore<\/td>\n<\/tr>\n<tr>\n<td>FY26 net profit<\/td>\n<td>Rs 1,064 crore<\/td>\n<td>Rs 1,442 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> table shows Max trading at a <strong>P\/E of 71.23<\/strong> and 8.68 times book, against 56.96 and 5.77 for Fortis. The hospital industry <strong>P\/E<\/strong> is 62.49, so Max trades above the sector and Fortis below it.<\/p>\n<p>Max has the higher <strong>return on equity<\/strong> at 12.18% against 9.91% for Fortis. Both carry modest debt, with debt to equity of 0.33 for Max and 0.30 for Fortis.<\/p>\n<p>Fortis&#8217; share price of Rs 803.20 is about 20.5% below its <strong>52-week high<\/strong> of Rs 1,010.10. Max at Rs 1,009.90 is about 14.8% below its high of Rs 1,185.40.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_vs_Max_Healthcare_Institute_Q2_FY27_Results\"><\/span><strong>Fortis Healthcare vs Max Healthcare Institute Q2 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Figures below are consolidated revenue and <strong>net profit<\/strong> for the quarter ended 30 September 2026.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>Fortis Healthcare vs Max Healthcare Institute Q2 FY27 (Sep 2026 quarter)<\/th>\n<th>Fortis Healthcare<\/th>\n<th>Max Healthcare Institute<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue Q2 FY27<\/td>\n<td>Rs 2,742 crore<\/td>\n<td>Rs 2,610 crore<\/td>\n<\/tr>\n<tr>\n<td>Revenue Q2 FY26<\/td>\n<td>Rs 2,354 crore<\/td>\n<td>Rs 2,168 crore<\/td>\n<\/tr>\n<tr>\n<td>Revenue change YoY<\/td>\n<td>+16.5%<\/td>\n<td>+20.4%<\/td>\n<\/tr>\n<tr>\n<td>Net profit Q2 FY27<\/td>\n<td>Rs 320.5 crore<\/td>\n<td>Rs 414.4 crore<\/td>\n<\/tr>\n<tr>\n<td>Net profit Q2 FY26<\/td>\n<td>Rs 328.8 crore<\/td>\n<td>Rs 491.3 crore<\/td>\n<\/tr>\n<tr>\n<td>Net profit change YoY<\/td>\n<td>-2.5%<\/td>\n<td>-15.6%<\/td>\n<\/tr>\n<tr>\n<td>Net profit Q1 FY27<\/td>\n<td>Rs 272.8 crore<\/td>\n<td>Rs 323.0 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the <strong>Q2 FY27 results<\/strong>, Fortis&#8217; revenue rose 16.5% to Rs 2,742 crore, and <strong>net profit<\/strong> slipped 2.5% to Rs 320.5 crore. Its <strong>operating margin<\/strong> eased to 23.4% from 26.0%, though profit rose from Rs 272.8 crore in the June quarter.<\/p>\n<p>Max Healthcare&#8217;s revenue rose 20.4% to Rs 2,610 crore and <strong>net profit<\/strong> fell 15.7% to Rs 414.4 crore. The year-ago figure of Rs 491.3 crore was well above its usual run-rate, and profit rose sharply from Rs 323 crore in Q1 FY27. Its <strong>operating margin<\/strong> improved to 29.3%.<\/p>\n<p>For <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong>, both chains grew revenue strongly. Max held and slightly improved its margin, while Fortis saw some margin pressure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_vs_Max_Healthcare_Valuation_Drivers_for_2027\"><\/span><strong>Fortis Healthcare vs Max Healthcare Valuation Drivers for 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Max_Healthcare_new_beds_in_premium_markets\"><\/span><strong>Max Healthcare: new beds in premium markets<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Max&#8217;s valuation premium rests on its plan to add beds in high-demand cities while keeping margins high. New hospitals usually take time to reach full occupancy, so expansion can weigh on margins before it adds to profit.<\/p>\n<p>Its FY26 <strong>net profit<\/strong> rose about 34% to Rs 1,442 crore on revenue of Rs 8,536 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Fortis_network_growth_and_diagnostics\"><\/span><strong>Fortis: network growth and diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fortis&#8217; FY26 revenue rose about 17% to Rs 9,179 crore and net profit about 31% to Rs 1,064 crore. Its growth in 2027 depends on adding beds at existing hospitals, improving occupancy and growing its diagnostics arm.<\/p>\n<p>In the <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> valuation debate, Fortis would need steady margin gains to move closer to Max&#8217;s multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Industry_tailwinds\"><\/span><strong>Industry tailwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising health insurance coverage, an ageing population and demand for complex treatments support all large hospital chains. Medical tourism into Delhi NCR also helps both companies. Regulatory caps on prices for some procedures remain a sector risk.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Compare hospital stocks on the Univest Screener<\/a><\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_in_Fortis_Healthcare_vs_Max_Healthcare_Institute\"><\/span><strong>Risks in Fortis Healthcare vs Max Healthcare Institute<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Risks_for_Fortis_Healthcare\"><\/span><strong>Risks for Fortis Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fortis&#8217; main risk is margin pressure as it adds capacity and runs a lower-margin diagnostics business. Its profit slipped in Q2 FY27 despite strong revenue growth. Foreign institutions cut their stake from 27.90% to 23.19%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Risks_for_Max_Healthcare_Institute\"><\/span><strong>Risks for Max Healthcare Institute<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the Fortis Healthcare vs Max Healthcare Institute risk check, Max&#8217;s main risk is its high valuation. A <strong>P\/E<\/strong> of 71.23 leaves little room for delays in new hospitals or margin dips. Foreign institutions cut their stake sharply from 51.80% to 40.52% over the year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_vs_Max_Healthcare_Institute_Shareholding\"><\/span><strong>Fortis Healthcare vs Max Healthcare Institute Shareholding<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>Fortis Healthcare vs Max Healthcare Institute shareholding (Sep &#8217;26, change vs Sep &#8217;25)<\/th>\n<th>Fortis Healthcare<\/th>\n<th>Max Healthcare Institute<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Promoters<\/td>\n<td>31.17% (+0.00 pts)<\/td>\n<td>23.71% (-0.03 pts)<\/td>\n<\/tr>\n<tr>\n<td>Foreign institutions (FII)<\/td>\n<td>23.19% (-4.71 pts)<\/td>\n<td>40.52% (-11.28 pts)<\/td>\n<\/tr>\n<tr>\n<td>Domestic institutions (DII)<\/td>\n<td>34.46% (+5.32 pts)<\/td>\n<td>31.00% (+10.97 pts)<\/td>\n<\/tr>\n<tr>\n<td>Public and others<\/td>\n<td>11.18% (-0.61 pts)<\/td>\n<td>4.76% (+0.33 pts)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Fortis&#8217; promoter IHH Healthcare holds 31.17%, unchanged over the year. Domestic institutions raised their stake from 29.14% to 34.46%.<\/p>\n<p>Max promoters hold 23.71%. Domestic institutions raised their stake from 20.03% to 31.00%, while foreign institutions sold about 11 points. In <strong>Fortis Healthcare vs Max Healthcare Institute<\/strong>, domestic funds have become much larger holders of both stocks.<\/p>\n<p style=\"margin-top:24px;\"><strong>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Fortis and Max Healthcare live and follow daily healthcare research.<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Which_Investor_Does_Each_Hospital_Stock_Suit\"><\/span><strong>Which Investor Does Each Hospital Stock Suit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_suits_investors_who_want_scale_at_a_lower_multiple\"><\/span><strong>Fortis Healthcare suits investors who want scale at a lower multiple<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Within Fortis Healthcare vs Max Healthcare Institute, Fortis fits investors who want a large hospital network with a diagnostics arm, backed by a global promoter, at a <strong>P\/E<\/strong> below the sector. They need to accept lower margins than Max.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Max_Healthcare_Institute_suits_premium-growth_investors\"><\/span><strong>Max Healthcare Institute suits premium-growth investors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Max fits investors who value high margins, a premium patient mix and expansion in strong markets. They need to accept a P\/E above 70.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_View_on_Fortis_Healthcare_vs_Max_Healthcare_Institute\"><\/span><strong>Final View on Fortis Healthcare vs Max Healthcare Institute<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Fortis Healthcare vs Max Healthcare Institute<\/strong> shows how margins shape valuations in healthcare. Max earns a 29.3% <strong>operating margin<\/strong> and trades at 71.23 times earnings. Fortis earns 23.4% and trades at 56.96 times. Both grew revenue strongly in Q2 FY27 while profit slipped.<\/p>\n<p>The Fortis Healthcare vs Max Healthcare Institute gap in 2027 will depend on how quickly new beds fill up and whether margins hold. Occupancy and revenue per bed are the numbers to watch.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are drawn from publicly available information and company disclosures, and they may change after publication. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Fortis_Healthcare_vs_Max_Healthcare_Institute\"><\/span><strong>FAQs on Fortis Healthcare vs Max Healthcare Institute<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Max_Healthcares_profit_fall_in_Q2_FY27\"><\/span><strong>Why did Max Healthcare&#x27;s profit fall in Q2 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Max Healthcare&#x27;s net profit fell 15.7% to Rs 414.4 crore in Q2 FY27, against Rs 491.3 crore a year earlier. The year-ago figure was well above its usual quarterly level. Revenue rose 20.4% to Rs 2,610 crore, and profit grew sharply from Rs 323 crore in the June quarter. Its operating margin improved to 29.3%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Fortis_Healthcare_perform_in_Q2_FY27\"><\/span><strong>How did Fortis Healthcare perform in Q2 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis&#x27; revenue rose 16.5% to Rs 2,742 crore, while net profit slipped 2.5% to Rs 320.5 crore in Q2 FY27. Its operating margin eased to 23.4% from 26.0%. Profit rose from Rs 272.8 crore in the June quarter. Its FY26 profit was Rs 1,064 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_Max_Healthcare_trade_at_a_higher_PE\"><\/span><strong>Why does Max Healthcare trade at a higher P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Max Healthcare trades at a P\/E of 71.23 against 56.96 for Fortis. The market pays more for Max&#x27;s higher operating margin and premium patient mix. Max also has a higher ROE of 12.18% against 9.91%. The hospital industry P\/E is 62.49.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_is_the_promoter_of_Fortis_Healthcare\"><\/span><strong>Who is the promoter of Fortis Healthcare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis Healthcare&#x27;s promoter is Malaysia&#x27;s IHH Healthcare, which holds 31.17%. Domestic institutions hold 34.46% and foreign institutions 23.19%. The public holds 11.18%. IHH is one of Asia&#x27;s largest hospital operators.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_hospital_chain_has_higher_FY26_revenue\"><\/span><strong>Which hospital chain has higher FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis Healthcare reported FY26 revenue of Rs 9,179 crore against Rs 8,536 crore for Max Healthcare. Max had higher FY26 net profit at Rs 1,442 crore against Rs 1,064 crore for Fortis. Max&#x27;s higher margin explains the gap. Both grew revenue by about 17% to 19%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_far_are_both_stocks_from_their_52-week_highs\"><\/span><strong>How far are both stocks from their 52-week highs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis closed at Rs 803.20 on 16 November 2026, about 20.5% below its 52-week high of Rs 1,010.10. Max closed at Rs 1,009.90, about 14.8% below its high of Rs 1,185.40. Fortis&#x27; 52-week low is Rs 704.95 and Max&#x27;s is Rs 797. Prices change daily.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Fortis_Healthcare_vs_Max_Healthcare_Institute_a_buy_or_sell_decision\"><\/span><strong>Is Fortis Healthcare vs Max Healthcare Institute a buy or sell decision?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This Fortis Healthcare vs Max Healthcare Institute comparison is educational and does not give a buy or sell call. Max offers higher margins at a P\/E of 71.23, and Fortis offers a larger network at 56.96. Both depend on new capacity and occupancy. Investors should consult a SEBI-registered adviser before deciding.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did Max Healthcare's profit fall in Q2 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Max Healthcare's net profit fell 15.7% to Rs 414.4 crore in Q2 FY27, against Rs 491.3 crore a year earlier. The year-ago figure was well above its usual quarterly level. Revenue rose 20.4% to Rs 2,610 crore, and profit grew sharply from Rs 323 crore in the June quarter. Its operating margin improved to 29.3%.\"}},{\"@type\":\"Question\",\"name\":\"How did Fortis Healthcare perform in Q2 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis' revenue rose 16.5% to Rs 2,742 crore, while net profit slipped 2.5% to Rs 320.5 crore in Q2 FY27. Its operating margin eased to 23.4% from 26.0%. Profit rose from Rs 272.8 crore in the June quarter. Its FY26 profit was Rs 1,064 crore.\"}},{\"@type\":\"Question\",\"name\":\"Why does Max Healthcare trade at a higher P\/E?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Max Healthcare trades at a P\/E of 71.23 against 56.96 for Fortis. The market pays more for Max's higher operating margin and premium patient mix. Max also has a higher ROE of 12.18% against 9.91%. The hospital industry P\/E is 62.49.\"}},{\"@type\":\"Question\",\"name\":\"Who is the promoter of Fortis Healthcare?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis Healthcare's promoter is Malaysia's IHH Healthcare, which holds 31.17%. Domestic institutions hold 34.46% and foreign institutions 23.19%. The public holds 11.18%. IHH is one of Asia's largest hospital operators.\"}},{\"@type\":\"Question\",\"name\":\"Which hospital chain has higher FY26 revenue?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis Healthcare reported FY26 revenue of Rs 9,179 crore against Rs 8,536 crore for Max Healthcare. Max had higher FY26 net profit at Rs 1,442 crore against Rs 1,064 crore for Fortis. Max's higher margin explains the gap. Both grew revenue by about 17% to 19%.\"}},{\"@type\":\"Question\",\"name\":\"How far are both stocks from their 52-week highs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis closed at Rs 803.20 on 16 November 2026, about 20.5% below its 52-week high of Rs 1,010.10. Max closed at Rs 1,009.90, about 14.8% below its high of Rs 1,185.40. Fortis' 52-week low is Rs 704.95 and Max's is Rs 797. Prices change daily.\"}},{\"@type\":\"Question\",\"name\":\"Is Fortis Healthcare vs Max Healthcare Institute a buy or sell decision?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This Fortis Healthcare vs Max Healthcare Institute comparison is educational and does not give a buy or sell call. Max offers higher margins at a P\/E of 71.23, and Fortis offers a larger network at 56.96. Both depend on new capacity and occupancy. Investors should consult a SEBI-registered adviser before deciding.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fortis Healthcare vs Max Healthcare Institute 2027: both grew Q2 FY27 revenue in double digits while profit slipped, yet Max trades at 71.23 times earnings and Fortis at 56.96. A full look at the valuation premium.<\/p>\n","protected":false},"author":28,"featured_media":350204,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[24444,7543,7594,13896,18947],"class_list":["post-350207","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-24444","tag-fortis-healthcare","tag-hospitals","tag-max-healthcare-institute","tag-stock-comparison"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["350204"],"rank_math_title":["Fortis Healthcare vs Max Healthcare Institute 2027"],"rank_math_description":["Fortis Healthcare vs Max Healthcare Institute 2027: valuation premium, Q2 FY27 results, margins, ROE, shareholding and share price of two hospital chains."],"rank_math_focus_keyword":["Fortis Healthcare vs Max Healthcare Institute"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/fortis-healthcare-vs-max-healthcare-institute-2027-the-market-pays-71x-for-one.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=350207"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350207\/revisions"}],"predecessor-version":[{"id":350209,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350207\/revisions\/350209"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/350204"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=350207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=350207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=350207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}